Chest
Volume 108, Issue 3, September 1995, Pages 754-758
Journal home page for Chest

Clinical Investigations: Miscellaneous
Prevention of Malignant Seeding After Invasive Diagnostic Procedures in Patients With Pleural Mesothelioma: A Randomized Trial of Local Radiotherapy

https://doi.org/10.1378/chest.108.3.754Get rights and content

The purpose of this randomized prospective study was to assess the efficacy of local radiotherapy in preventing malignant seeding along invasive diagnostic procedures (cytology, needle biopsy, thoracoscopy, or chest tube placement) in patients with malignant pleural mesothelioma. Forty consecutive patients with histologically proven malignant mesothelioma were enrolled. Twenty patients received three daily sessions of radiotherapy at a dosage of 7 Gy 10 to 15 days after thoracoscopy. The other 20 patients did not receive radiotherapy. None of the 20 patients treated developed entry tract metastasis. In contrast, 8 of the 20 (40%) patients who were not treated developed metastases. These findings confirm the efficacy and safety of early local radiotherapy in preventing malignant seeding after invasive diagnostic procedures in patients with malignant pleural mesothelioma.

Section snippets

Patients

This study included 40 consecutive patients (33 men and 7 women; mean age, 66 ± 3 years) with pleural mesothelioma whose life expectancy was over 3 months at the time of diagnosis. All patients had undergone pleural cytologic study and Abrams needle biopsy within 1 month before thoracoscopy, and puncture sites were still clearly visible. Thirteen patients had positive cytologic findings (meaning detection of “malignant cells”) and 6 had positive needle biopsy results.

Thoracoscopy was performed

RESULTS

Patients were randomly divided into two groups of 20. In one group, radiotherapy was performed and in the other it was not. As shown in Table 1, there was no significant difference between these two groups with regard to clinical status, treatment, or median survival.

None of the patients in the treatment group developed subcutaneous nodules. Conversely, eight patients (40%) in the untreated group developed subcutaneous nodules (p<0.001) at entry sites of thoracoscopy trocars or chest tubes

DISCUSSION

This study confirms the efficacy and safety of local radiotherapy in preventing tract metastases after cytologic study, needle biopsy, thoracoscopy, or chest tube placement in patients with malignant mesothelioma.

This result contrasts sharply with the poor effectiveness of radiotherapy for pleural mesothelioma.23 Response rates have never exceeded 15%.24 In their series including 49 patients treated by radiation therapy, surgical resection, and chemotherapy, Mattson et al25 noted one complete

REFERENCES (35)

  • ElmesPC et al.

    The clinical aspects of mesothelioma.

    Q J Med

    (1976)
  • Van OoijenB et al.

    Subcutaneous tumor growth complicating the positioning of Denver shunt and intrapleural port-a-cath in mesothelioma patients.

    Eur J Surg Oncol

    (1992)
  • KnappmannJ.

    Beobachtungen an 251 obduzierten Mesotheliomfällen in Hamburg (1958-1968).

    Pneumologie

    (1972)
  • MiechG et al.

    Les risques de la ponction biopsie transpariétale: l'inoculation néoplasique (à propos de 2 cas).

    Presse Med

    (1967)
  • JonesFL.

    Subcutaneous implantation of cancer: a rare complication of pleural biopsy.

    Chest

    (1970)
  • De LajartreAY et al.

    Aspects évolutifs des mésothéliomes pleuraux diffus.

    Rev Fr Mal Resp

    (1979)
  • AdamsVI et al.

    Diffuse malignant mesothelioma of the pleura: diagnostic criteria based on an autopsy study.

    Am J Clin Pathol

    (1984)
  • RatzerER et al.

    Pleural mesotheliomas: clinical experience with 37 patients.

    AJR

    (1967)
  • WhitwellF et al.

    Diffuse malignant pleural mesothelioma and asbestos exposure.

    Thorax

    (1971)
  • BrennerJ et al.

    Malignant mesothelioma of the pleura: review of 123 patients.

    Cancer

    (1982)
  • LawMR et al.

    Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.

    Eur J Respir Dis

    (1984)
  • RuffieP et al.

    Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

    J Clin Oncol

    (1989)
  • StewartBN et al.

    Subcutaneous implantation of cancer following thoracentesis.

    Chest

    (1974)
  • BoutinC et al.

    Les biopsies pleurales: incidents et rentabilité actuelle de la biopsie à l'aiguille d'Abrams: A propos de 1,000 prélèvements: intérêt de la biopsie pleuroscopique.

    Poumon-Coeur

    (1975)
  • MigueresJ et al.

    Note on the complications of pleural needle biopsy: neoplastic seeding of the wall (a propos of 300 effusions and 440 puncture biopsies).

    Poumon-Coeur

    (1975)
  • AntmanK et al.

    Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985.

    J Clin Oncol

    (1988)
  • RushVW et al.

    Intrapleural cisplatine and cytarabine in the management of malignant pleural effusions: a lung cancer study group trial.

    J Clin Oncol

    (1991)
  • Cited by (439)

    • Evolution of semi-rigid thoracoscopy

      2022, Indian Journal of Tuberculosis
      Citation Excerpt :

      Semi-rigid thoracoscopy is simple, safe procedure with a very high sensitivity of 93–95% in cases of malignancies.22,23 In cases of primary pleural malignancies like mesothelioma, pleurodesis can also be done in the same setting after taking the biopsy, hence reducing the number of procedures which can cause tumor seeding in the tract of incision for biopsy.24–27 Sometimes etiology of pleural effusions remains undiagnosed despite repeated pleural aspirations and closed pleural biopsy.28

    • Malignant Pleural Effusions

      2021, Clinics in Chest Medicine
    View all citing articles on Scopus
    View full text